Pemigatinib

About

Therapy type: Targeted therapy

Therapy strategy: FGFR inhibition

Mappings

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) FGFR2::v Cholangiocarcinoma Pemigatinib
Sensitivity (+) FGFR2 rearrangements Cholangiocarcinoma Pemigatinib
Sensitivity (+) FGFR1 rearrangements Myeloid/Lymphoid Neoplasms Pemigatinib